Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Meisner

Showing results (11-20 of 156) with videos related to

Pageof 16
Sort By:
Munchener Medizinische Wochenschrift (1950)|March 2, 1973
[Carcinoid of the appendix]H Meisner
Journal of Lipid Research|November 1, 1978
Antilipolytic effects of chlorophenoxyisobutyrate and warfarin in adipocytesH Meisner, S Taylor
Pediatric Cardiology|June 24, 1998
Atrioventricular septal defectH Meisner, T Guenther
Journal of Lipid Research|November 1, 1977
pH as an indicator of free fatty acid release from adipocytesH Meisner, K Tenney
Developments in Toxicology and Environmental Science|January 1, 1986
Effect of ochratoxin A on gene expression in rat kidneysH Meisner, M Cimbala
Biochemical Pharmacology|February 15, 1986
Changes of renal mRNA species abundance by ochratoxin AH Meisner, L Polsinelli
Molecular Pharmacology|March 1, 1978
Competitive binding of long-chain free fatty acids, octanoate, and chlorophenoxyisobutyrate to albuminH Meisner, K Neet
Developments in Toxicology and Environmental Science|January 1, 1986
Phosphoenolpyruvate carboxykinase as a selective indicator of ochratoxin A induced nephropathyH Meisner, P Krogh
Archives of Biochemistry and Biophysics|April 15, 1981
Ochratoxin A, an in vivo inhibitor of renal phosphoenolpyruvate carboxykinaseH Meisner, P Meisner
Biochemistry|July 2, 1974
Ochratoxin A, an inhibitor of mitochondrial transport systemsH Meisner, S Chan
Pageof 16

Showing results (11-20 of 156) with videos related to

Sort By:
Pageof 16
Munchener Medizinische Wochenschrift (1950)|March 2, 1973
[Carcinoid of the appendix]H Meisner
Journal of Lipid Research|November 1, 1978
Antilipolytic effects of chlorophenoxyisobutyrate and warfarin in adipocytesH Meisner, S Taylor
Pediatric Cardiology|June 24, 1998
Atrioventricular septal defectH Meisner, T Guenther
Journal of Lipid Research|November 1, 1977
pH as an indicator of free fatty acid release from adipocytesH Meisner, K Tenney
Developments in Toxicology and Environmental Science|January 1, 1986
Effect of ochratoxin A on gene expression in rat kidneysH Meisner, M Cimbala
Biochemical Pharmacology|February 15, 1986
Changes of renal mRNA species abundance by ochratoxin AH Meisner, L Polsinelli
Molecular Pharmacology|March 1, 1978
Competitive binding of long-chain free fatty acids, octanoate, and chlorophenoxyisobutyrate to albuminH Meisner, K Neet
Developments in Toxicology and Environmental Science|January 1, 1986
Phosphoenolpyruvate carboxykinase as a selective indicator of ochratoxin A induced nephropathyH Meisner, P Krogh
Archives of Biochemistry and Biophysics|April 15, 1981
Ochratoxin A, an in vivo inhibitor of renal phosphoenolpyruvate carboxykinaseH Meisner, P Meisner
Biochemistry|July 2, 1974
Ochratoxin A, an inhibitor of mitochondrial transport systemsH Meisner, S Chan
Pageof 16